Pediatrik Nöroloji Hastalıklarında Endokrin Aciller ve Endokrin Hastalıkların Nörolojik Bulguları
Özet
Çocuk nörolojisi ve endokrinolojisi, birçok hastalıkta ortak yönetim gerektiren iç içe geçmiş alanlardır. Endokrinolojik aciller sıklıkla elektrolit dengesizlikleri ve kan şekeri düzensizlikleri olarak ortaya çıkarken, endokrin bozukluklar da intrakraniyal hipertansiyon veya nöromüsküler sorunlar gibi ciddi nörolojik bulgulara yol açabilir. Bu kesişim noktalarının erken fark edilmesi ve disiplinler arası tedavi yaklaşımı, hayati komplikasyonları önlemek için kritik öneme sahiptir.
Pediatric neurology and endocrinology are interconnected fields requiring joint management in many clinical conditions. While endocrine emergencies often manifest as electrolyte imbalances and blood glucose irregularities, various endocrine disorders can also lead to significant neurological symptoms such as intracranial hypertension or neuromuscular issues. Timely identification and an interdisciplinary treatment approach at these intersections are critical for preventing life-threatening complications.
Referanslar
Cui H, He G, Yang S, Lv Y, Jiang Z, Gang X, Wang G. Inappropriate Antidiuretic Hormone Secretion and Cerebral Salt-Wasting Syndromes in Neurological Patients. Front Neurosci. 2019 8;13:1170
Moritz ML. Syndrome of Inappropriate Antidiuresis. Pediatr Clin North Am. 2019;66:209-226.
Cuesta M, Thompson CJ. The syndrome of inappropriate antidiuresis (SIAD). Best Pract Res Clin Endocrinol Metab. 2016;30:175-87.
Gutierrez OM, Lin HY. Refractory hyponatremia. Kidney Int. 2007;71:79-82.
Naval NS, Stevens RD, Mirski MA, Bhardwaj A. Controversies in the management of aneurysmal subarachnoid hemorrhage. Crit Care Med. 2006;34:511-24.
Bettinelli A, Longoni L, Tammaro F, Faré PB, Garzoni L, Bianchetti MG. Renal salt-wasting syndrome in children with intracranial disorders. Pediatr Nephrol. 2012;27:733-9.
Yee AH, Burns JD, Wijdicks EF. Cerebral salt wasting: pathophysiology, diagnosis, and treatment. Neurosurg Clin N Am. 2010;21:339-52.
Filippella M, Cappabianca P, Cavallo LM, Faggiano A, Lombardi G, de DE, Colao A. Very delayed hyponatremia after surgery and radiotherapy for a pituitary macroadenoma. J Endocrinol Invest. 2002;25:163-8.
Dalan R, Chin H, Hoe J, Chen A, Tan H, Boehm BO, Chua KS. Adipsic Diabetes Insipidus-The Challenging Combination of Polyuria and Adipsia: A Case Report and Review of Literature. Front Endocrinol (Lausanne). 2019:18;10:630.
Robertson GL. Abnormalities of thirst regulation. Kidney Int. 1984;25:460-9.
Crowley RK, Sherlock M, Agha A, Smith D, Thompson CJ. Clinical insights into adipsic diabetes insipidus: a large case series. Clin Endocrinol (Oxf). 2007;66:475-82.
Mavrakis AN, Tritos NA. Diabetes insipidus with deficient thirst: report of a patient and review of the literature. Am J Kidney Dis. 2008;51:851-9.
Di Iorgi N, Morana G, Napoli F, Allegri AE, Rossi A, Maghnie M. Management of diabetes insipidus and adipsia in the child. Best Pract Res Clin Endocrinol Metab. 2015;29:415-36.
Hansen LK, Rittig S, Robertson GL. Genetic basis of familial neurohypophyseal diabetes insipidus. Trends Endocrinol Metab 1997;8:363-372
Maghnie M, Cosi G, Genovese E, Manca-Bitti ML, Cohen A, Zecca S, Tinelli C, Gallucci M, Bernasconi S, Boscherini B, Severi F, Aricò M. Central diabetes insipidus in children and young adults. N Engl J Med. 2000 5;343:998-1007.
Saifan C, Nasr R, Mehta S, Sharma Acharya P, Perrera I, Faddoul G, Nalluri N, Kesavan M, Azzi Y, El-Sayegh S. Diabetes insipidus: a challenging diagnosis with new drug therapies. ISRN Nephrol. 2013;24;2013:797620.
Adams NC, Farrell TP, O'Shea A, O'Hare A, Thornton J, Power S, Brennan P, Looby S. Neuroimaging of central diabetes insipidus-when, how and findings. Neuroradiology. 2018;60:995-1012.
Patti G, Ibba A, Morana G, Napoli F, Fava D, di Iorgi N, Maghnie M. Central diabetes insipidus in children: Diagnosis and management. Best Pract Res Clin Endocrinol Metab. 2020;34(5):101440.
Charmandari E, Nicolaides NC, Chrousos GP. Adrenal insufficiency. Lancet. 2014:21;383:2152-67.
Gaiani F, Gismondi P, Minelli R, Casadio G, de'Angelis N, Fornaroli F, de'Angelis GL, Manfredi M. Case report of a familial triple: a syndrome and review of the literature. Medicine (Baltimore). 2020;29;99:e20474.
Kallabi F, Belghuith N, Aloulou H, Kammoun et al. Clinical and Genetic Characterization of 26 Tunisian Patients with Allgrove Syndrome. Arch Med Res. 2016 ;47:105-10.
Berger J, Forss-Petter S, Eichler FS. Pathophysiology of X-linked adrenoleukodystrophy. Biochimie. 2014;98:135-42.
Powers JM, Moser HW, Moser AB, Schaumburg HH. Fetal adrenoleukodystrophy: the significance of pathologic lesions in adrenal gland and testis. Hum Pathol. 1982;13:1013-9.
Steinberg SJ, Raymond GV, Braverman NE, Moser AB. Zellweger Spectrum Disorder. 2003 Dec 12 [updated 2020 Oct 29]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2021.
Klouwer FC, Berendse K, Ferdinandusse S, Wanders RJ, Engelen M, Poll-The BT. Zellweger spectrum disorders: clinical overview and management approach. Orphanet J Rare Dis. 2015 ;1;10:151.
Donoghue SE, Pitt JJ, Boneh A, White SM. Smith-Lemli-Opitz syndrome: clinical and biochemical correlates. J Pediatr Endocrinol Metab. 2018;28;3:451-459.
Carter BL, Small RE, Mandel MD, Starkman MT. Phenytoin-induced hyperglycemia. Am J Hosp Pharm. 1981;38:1508-12.
Selda KESKİN GÜLER,1 Nalan GÜNEŞ,1 Burcu Gökçe ÇOKAL,1 Tahir YOLDAŞ,1 Elif Banu SÖKER2 Development of Insulin Resistance in Patients with Epilepsy During Valproate and Carbamazepine Monotherapy Epilepsi 2016;22:102-107
Demirbilek H, Hussain K. Congenital Hyperinsulinism: Diagnosis and Treatment Update. J Clin Res Pediatr Endocrinol. 2017 30;9(Suppl 2):69-87.
Korf BR. Neurofibromatosis. Handb Clin Neurol. 2013;111:333-40.
Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM, Oldfield EH. von Hippel-Lindau disease. Lancet. 2003; 14;361:2059-67.
Per H, Canpolat M, Gümüş H, Poyrazoğlu HG, Yıkılmaz A, Karaküçük S, Doğan H, Kumandaş S. Clinical spectrum of the pseudotumor cerebri in children: etiological, clinical features, treatment and prognosis. Brain Dev. 2013;35:561-8.
Shenouda S, Al-Farawi K, Dolan J, Flesher SL. Idiopathic intracranial hypertension as a presenting sign of adrenal insufficiency. SAGE Open Med Case Rep. 2018 Jan 17;6:2050313X17753787.
Eren Y. Clinical Features of Pseudotumour Cerebri Syndrome Syndrome: A Retrospective Evaluation of 60 Patients. Journal of Ankara University Faculty of Medicine 72:61-65
Ozge A, Bolay H. Intracranial hypotension and hypertension in children and adolescents. Curr Pain Headache Rep. 2014;18:430.
Matthews YY, Dean F, Lim MJ, Mclachlan K, Rigby AS, Solanki GA, White CP, Whitehouse WP, Kennedy CR. Pseudotumor cerebri syndrome in childhood: incidence, clinical profile and risk factors in a national prospective population-based cohort study. Arch Dis Child. 2017;102:715-721.
Burkett JG, Ailani J. An Up to Date Review of Pseudotumor Cerebri Syndrome. Curr Neurol Neurosci Rep. 2018; 2;18:33.
Irimia Sieira P., Mínguez Olaondo A., Martínez-Vila E., Ruttledge M. (2019) Neurological Manifestations of Endocrine Disorders. In: Portincasa P., Frühbeck G. (eds) Endocrinology and Systemic Diseases. Endocrinology. Springer, Cham.
Molitch ME. Diagnosis and Treatment of Pituitary Adenomas: A Review. JAMA. 2017 7;317:516-524.
Levy MJ, Matharu MS, Meeran K, Powell M, Goadsby PJ. The clinical characteristics of headache in patients with pituitary tumours. Brain. 2005;128:1921-30.
Melmed S, Bronstein MD, Chanson P, Klibanski A, Casanueva FF, Wass JAH, Strasburger CJ, Luger A, Clemmons DR, Giustina A. A Consensus Statement on acromegaly therapeutic outcomes. Nat Rev Endocrinol. 2018;14:552-561.
Vilar L, Vilar CF, Lyra R, Lyra R, Naves LA. Acromegaly: clinical features at diagnosis. Pituitary. 2017;20:22-32.
Alshekhlee A, Kaminski HJ, Ruff RL. Neuromuscular manifestations of endocrine disorders. Neurol Clin. 2002;20:35-58.
Cruz-Flores S. Neurological Complications of Endocrine Emergencies. Curr Neurol Neurosci Rep. 2021; 11;21:21
Ishii M. Neurologic complications of nondiabetic endocrine disorders. Continuum (Minneap Minn). 2014 Jun;20(3 Neurology of Systemic Disease):560-79.
Yu J. Endocrine disorders and the neurologic manifestations. Ann Pediatr Endocrinol Metab. 2014;19:184-9
Root JM, Vargas M, Garibaldi LR, Saladino RA. Pediatric Patient With Altered Mental Status and Hypoxemia: Case Report. Pediatr Emerg Care. 2017 ;33:486-488.
Rizzo LFL, Mana DL, Bruno OD, Wartofsky L. Coma mixedematoso [Myxedema coma]. Medicina (B Aires). 2017;77:321-328.
Ishii M. Endocrine Emergencies With Neurologic Manifestations. Continuum (Minneap Minn). 2017;23(3, Neurology of Systemic Disease):778-801.
Klubo-Gwiezdzinska J, Wartofsky L. Thyroid emergencies. Med Clin North Am 2012;96:385-403.
Dubbs SB, Spangler R. Hypothyroidism: causes, killers, and life-saving treatments. Emerg Med Clin North Am. 2014;32:303-17.
Douglas M. Neurology of endocrine disease. Clin Med (Lond). 2010;10:387-90.
Carvalho KS, Grunwald T, De Luca F. Neurological Complications of Endocrine Disease. Semin Pediatr Neurol. 2017;24:33-42.
Kung AW. Neuromuscular complications of thyrotoxicosis. Clin Endocrinol (Oxf). 2007 ;67:645-50.
Duyff RF, Van den Bosch J, Laman DM, van Loon BJ, Linssen WH. Neuromuscular findings in thyroid dysfunction: a prospective clinical and electrodiagnostic study. J Neurol Neurosurg Psychiatry. 2000;68:750-5.
Fralick M, Sarma S. Thyrotoxic Periodic Paralysis. N Engl J Med. 2021 May 13;384:e71.
Chiha M, Samarasinghe S, Kabaker AS. Thyroid storm: an updated review. J Intensive Care Med. 2015;30:131-40. *
Agrawal L, Habib Z, Emanuele NV. Neurologic disorders of mineral metabolism and parathyroid disease. Handb Clin Neurol. 2014;120:737-48.
Shoback D. Clinical practice. Hypoparathyroidism. N Engl J Med. 2008; 24;359:391-403.
Davies JH. Approach to the Child with Hypercalcaemia. Endocr Dev. 2015;28:101-18.
Keil MF, Zametkin A, Ryder C, Lodish M, Stratakis CA. Cases of Psychiatric Morbidity in Pediatric Patients After Remission of Cushing Syndrome. Pediatrics. 2016;137:e20152234.
Katzberg HD, Kassardjian CD. Toxic and Endocrine Myopathies. Continuum (Minneap Minn). 2016 ;22(6, Muscle and Neuromuscular Junction Disorders):1815-1828.
Loriaux DL. Diagnosis and Differential Diagnosis of Cushing's Syndrome. N Engl J Med. 2017 13;376:1451-59.
Nyenwe EA, Kitabchi AE. Evidence-based management of hyperglycemic emergencies in diabetes mellitus. Diabetes Res Clin Pract. 2011;94:340-51.
Vale TC, Freitas Dda S, Maciel RO, Miranda EC, Cardoso F. Teaching Video NeuroImages: hemichorea-hemiballismus secondary to nonketotic hyperglycemia. Neurology. 2013 Apr 16;80:e178.
Long B, Koyfman A. Emergency Medicine Myths: Cerebral Edema in Pediatric Diabetic Ketoacidosis and Intravenous Fluids. J Emerg Med. 2017;53:212-21.
Munshi MN. Cognitive Dysfunction in Older Adults With Diabetes: What a Clinician Needs to Know. Diabetes Care. 2017;40:461-467.
Charnogursky G, Lee H, Lopez N. Diabetic neuropathy. Handb Clin Neurol. 2014;120:773-85.
Sasaki H, Kawamura N, Dyck PJ, Dyck PJB, Kihara M, Low PA. Spectrum of diabetic neuropathies. Diabetol Int. 2020;11:87-96.
Vinik AI, Nevoret ML, Casellini C, Parson H. Diabetic neuropathy. Endocrinol Metab Clin North Am. 2013;42:747-87.
Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, Fish L, Heller SR, Rodriguez H, Rosenzweig J, Vigersky R; American Diabetes Association; Endocrine Society. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. J Clin Endocrinol Metab. 2013;98:1845-59.
Mohseni S. Neurologic damage in hypoglycemia. Handb Clin Neurol. 2014;126:513-32.
